Differential hepatic distribution of insulin receptor substrates causes selective insulin resistance in diabetes and obesity
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Hepatic insulin signalling involves insulin receptor substrates (Irs) 1/2, and is normally associated with the inhibition of gluconeogenesis and activation of lipogenesis. In diabetes and obesity, insulin no longer suppresses hepatic gluconeogenesis, while continuing to activate lipogenesis, a state referred to as ‘selective insulin resistance’. Here, we show that ‘selective insulin resistance’ is caused by the differential expression of Irs1 and Irs2 in different zones of the liver. We demonstrate that hepatic Irs2-knockout mice develop ‘selective insulin resistance’, whereas mice lacking in Irs1, or both Irs1 and Irs2, develop ‘total insulin resistance’. In obese diabetic mice, Irs1/2-mediated insulin signalling is impaired in the periportal zone, which is the primary site of gluconeogenesis, but enhanced in the perivenous zone, which is the primary site of lipogenesis. While hyperinsulinaemia reduces Irs2 expression in both the periportal and perivenous zones, Irs1 expression, which is predominantly in the perivenous zone, remains mostly unaffected. These data suggest that ‘selective insulin resistance’ is induced by the differential distribution, and alterations of hepatic Irs1 and Irs2 expression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“SREBP1c, which is controlled by both insulin signaling and insulin-independent pathways [2,20,75]”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [20]
The cited source says what the claim attributes to it.
In the citing paper
“The concept of hepatic zonation of insulin signaling components can also help explain the paradoxical coexistence of increased hepatic glucose output and increased hepatic lipogenesis in MASLD [15,20].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [20]
The cited source says what the claim attributes to it.
In the citing paper
“Studies suggest that IRS1 and IRS2 have distinct roles in regulating hepatic lipid metabolism [20,30,97].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [20]
The cited source says what the claim attributes to it.
In the citing paper
“Additionally, DNL is markedly decreased in LIRS1KO mice but not in LIRS2KO mice.”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [20]
The cited source says what the claim attributes to it.
In the citing paper
“This leads to impaired insulin signaling in gluconeogenic zones, resulting in insufficient suppression of HGP and thus contributing to systemic hyperglycemia.”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [20]
11 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wnt/β-Catenin Signaling in Development and Disease
Clevers, H. (2006) · Cell · doi:10.1016/j.cell.2006.10.018 · Cited by 5,568
Insulin signalling and the regulation of glucose and lipid metabolism
Saltiel, A. R., & Kahn, C. R. (2001) · Nature · doi:10.1038/414799a · Cited by 5,326
Critical nodes in signalling pathways: insights into insulin action
Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760
Energy Metabolism in the Liver
Rui, L. (2014) · Comprehensive Physiology · doi:10.1002/cphy.c130024 · Cited by 1,953
PPARγ Mediates High-Fat Diet–Induced Adipocyte Hypertrophy and Insulin Resistance
Kubota, N., Terauchi, Y., Miki, H., Tamemoto, H., Yamauchi, T., Komeda, K., Satoh, S., Nakano, R., Ishii, C., Sugiyama, T., et al. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80210-5 · Cited by 1,342
Self-citationMichael, M. D., Kulkarni, R. N., Postic, C., Previs, S. F., Shulman, G. I., Magnuson, M. A., & Kahn, C. R. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00015-8 · Cited by 1,296
Postic, C., & Girard, J. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34275 · Cited by 1,204
Selective versus Total Insulin Resistance: A Pathogenic Paradox
Brown, M. S., & Goldstein, J. L. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.12.009 · Cited by 965
SHIMOMURA, I. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00009-5 · Cited by 855
Shimano, H., Horton, J. D., Hammer, R. E., Shimomura, I., Brown, M. S., & Goldstein, J. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118951 · Cited by 816
Research works printed but not linked: 1
- Benhamouche, S. et al. Apc tumor suppressor gene is the "zonation-keeper" of mouse liver. Dev. Cell. 10, 759–770 (2006). · DOI · Paper page
Cited by
Items 101–142 of 142
Epigenetic regulation in MASLD – insight for therapeutic target discovery
Britsemmer, J. H., López‐Alcántara, N., & Kirchner, H. (2026) · Epigenomics · doi:10.1080/17501911.2026.2633978 · Cited by 3
“IRS2 is uniformly distributed, whereas IRS1 is more abundant within pericentral hepatocytes [69].”
Parini, F., Galla, R., Mulè, S., Musu, M., & Uberti, F. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27052375 · Cited by 3
Tang, S., Zheng, W., Wu, T., Song, S., & Ai, C. (2026) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5c11987 · Cited by 2
Gene regulatory mechanisms underlying sex- and age-dependent pathophysiology of MASLD
Morral, N. (2026) · Clinical Science · doi:10.1042/cs20250052 · Cited by 3
The Effect of Tff3 Deficiency on the Liver of Mice Exposed to a High-Fat Diet
Bazina, I., Šešelja, K., Pirman, T., Horvatić, A., Erman, A., Mihalj, M., & Lončar, M. B. (2025) · Biomedicines · doi:10.3390/biomedicines13051024 · Cited by 2
“This effect has been shown to be due in part to increased lipogenesis [47]; however, the analysis of de novo lipogenesis markers shows no changes in the liver of Tff3 − / − females compared to WT females (Figure 3b).”
Yin, Z., Cai, M., Weng, X., Liu, Z., & Zhang, G. (2019) · Polish Journal of Veterinary Sciences · doi:10.24425/pjvs.2019.129968 · Cited by 2
A fluorescent reporter assay of differential gene expression response to insulin in hepatocytes
McKimpson, W. M., & Accili, D. (2019) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00504.2018 · Cited by 2
“It has been suggested that there is differential distribution of insulin receptor substrates 1 and 2 within the periportal and perivenous zones (24).”
BackgroundPre-diabetes and diabetic neuropathy are associated with low serum levels of interleukin-9
Khalaf, N. F., Al-Rikabi, A. H. A., Salman, I. N., Saihood, Y. D., Nassurat, S. W., Jasim, O. H., & Ad'hiah, A. H. (2023) · Beni-Suef University Journal of Basic and Applied Sciences · doi:10.1186/s43088-023-00412-6 · Cited by 4
“Importantly, dysregulated expression of IRS1 and IRS2 has been linked to insulin resistance and obesity; both well recognized risk factors for diabetes [31, 32].”
BackgroundWhite, M. F. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch9 · Cited by 3
Li, H., Wang, Y., Ran, M., Gao, F., Zhu, B.-Y., Xiao, H.-Y., & Xu, C. (2024) · World Journal of Diabetes · doi:10.4239/wjd.v16.i2.97910 · Cited by 2
Tocheny, C. E., Buchwald, J. E., Dahlke, C. D., Fakih, H. H., Morgan, J. S., Summers, A., Silva, C. A., Jackson, S. O., Lee, J.-S., Card, M.-A., et al. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2026.01.033 · Cited by 2
Ren, X., Guo, Y., Li, B., Xu, T., Wang, B., Yang, L., Han, J. Z., Zhou, Y., & Zhou, B. (2026) · Environmental Science & Technology · doi:10.1021/acs.est.5c15793 · Cited by 1
Metabolic Dysfunction‐Associated Fatty Liver Disease: From Pathogenesis to Treatment
Cui, Z., Du, X., Amevor, F. K., Xia, Y., Yang, Y., & Liu, L. (2026) · MedComm · doi:10.1002/mco2.70832 · Cited by 1
Gastaldelli, A., Choi, E., Conde‐Knape, K., Göransson, O., Krook, A., Lehtonen, S. H., Roden, M., Schrauwen, P., Sparks, L. M., & Heni, M. (2026) · Diabetologia · doi:10.1007/s00125-026-06853-9 · Cited by 3
BRD7 improves glucose homeostasis independent of IRS proteins
Kim, Y., Lee, J. M., Han, Y., Tao, R., White, M. F., Liu, R., & Park, S. W. (2023) · Journal of Endocrinology · doi:10.1530/joe-23-0119 · Cited by 2
Kadowaki, T. (2016) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.105.1543
Self-citationPost-weaning metabolic programming by dietary monosaccharides
Bouwman, L. M. S. (2019) · doi:10.18174/495333
INSULIN RESISTANCE RELATED SIGNALING PATHWAYS IN THE LIVER
Wang, Y. (2020)
Matsushita, M., Awazawa, M., Kobayashi, N., Ikushima, Y. M., Soeda, K., Nakano, M., Muratani, M., Kobayashi, K., Blüher, M., Brüning, J. C., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3964212
Self-citationFerreira, G. D. S. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2021.tde-07012022-133712
Anthony, M. J. A. (2022) · RiuNet (Universitat Politècnica de València) · doi:10.4995/thesis/10251/188913
Kakimoto, P. A. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.46.2021.tde-10082023-115406
(2023) · Middle East Journal of Agriculture Research · doi:10.36632/mejar/2023.12.2.26
“…glucose homeostasis with a balance between glycogenesis (glucose storage) and gluconeogenesis (glucose output) Under normal circumstances, will insulin binds to receptors in the liver to elevate glucose consumption and glycogenesis to maintain levels glucose in the blood (Kubota et al., 2016).”
Delfira, A., Alimudin, T., & Rita, R. S. (2024) · International Journal of Research and Review · doi:10.52403/ijrr.20240175
Exploring mechanisms of insulin action and strategies to treat diabetes
Sasako, T. (2024) · Endocrine Journal · doi:10.1507/endocrj.ej24-0003 · Cited by 3
Self-citationInvestigating CR1 as an indicated Gene for mild cognitive impairment in type 2 diabetes mellitus
Zhou, X., Wang, S., Yu, D., & Niu, T. (2024) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-024-01449-y
“The liver plays an important role in maintaining glucose homeostasis and may contribute to the development of T2DM and IR through the production of hepatokines [13, 14].”
BackgroundSun, Q. L., Xie, L., An, H., Chen, W., Yang, Q., Wang, P., Tang, Y., & Peng, C. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1585030 · Cited by 1
Aster pekinensis Extract Mitigates High-Fat-Diet-Induced Obesity and Metabolic Dysfunction in Mice
Moon, H. J., Lee, S., Kim, G. W., Baek, Y., & Park, S.-I. (2026) · Animals · doi:10.3390/ani16020163
“We propose that improved insulin signaling, driven by reduced hepatic lipotoxicity and adipose inflammation, underlies these systemic glycemic benefits [34,54,55].”
Serotonin drives selective hepatic insulin resistance via HTR2A and HTR2BPreprint
Kim, H., Nam, J. E., HWANG, I., Choi, W. G., Choi, W., CHOI, W.-I., & Moon, Y.-A. (2026) · Research Square · doi:10.21203/rs.3.rs-8819291/v1
Foundations of Diabetes Technology
Joshi, D. M., Bhatt, H., & Patel, H. K. (2026) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898813635126010006
Obésité et insulinorésistance : quels déterminants ? : inflammation, masse grasse ou triglycérides ?
Boursier, G. (2017) · theses.fr (ABES) · doi:10.70675/82f62752zb2c1z4f8fz82e0z694691e674b8
Rôle de l'isoforme A du récepteur de l'insuline dans l'homéostasie et la carcinogenèse hépatiques
Léandre, F. (2024) · theses.fr (ABES) · doi:10.70675/df1bc445z5d98z462dzbc59za0d4015bcf04
Rôle de la kinase ATR dans la progression de la stéatose hépatique non alcoolique
Saroul-Aïnama, M. (2022) · theses.fr (ABES) · doi:10.70675/1fc5906az1637z451czab81z7529e034be63
Zhao, W., JIAO, X., Du, K., Sun, Q., Duan, J., Cao, Y., Shen, X., Said, Z., Karri, S. S., Ellsworth, P. N., et al. (2026) · Metabolism · doi:10.1016/j.metabol.2026.156630 · Cited by 1
Common Mechanisms of Insulin Signaling, Action, and Resistance
White, M. F. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-11985-9.00007-x
Li, Y., Li, H., Zhang, B., Wu, Q., & Long, H. (2026) · Frontiers in Gastroenterology · doi:10.3389/fgstr.2026.1859647
Duan, Z., Peng, J., Zhu, H., Ruan, B., & Cao, M. (2026) · Cytotechnology · doi:10.1007/s10616-026-01071-y
“PI3K transmits signals received by the insulin receptor to downstream targets, mediating the biological effects of insulin (Kubota et al. 2016).”
Ma, T., Jiang, H., Bai, C., Zhang, X., Zhang, Y., Guan, Y., Zhou, K., Zhao, J., Zuo, F., Nian, X., et al. (2026) · The FASEB Journal · doi:10.1096/fj.202601702rrrr
Perspectives on tissue-selective insulin derivatives
Hejl, M., & Jiráček, J. (2026) · Open Biology · doi:10.1098/rsob.260175
Mechanisms of Hepatic Insulin Resistance and Its Contribution to the Pathogenesis of Type 2 Diabetes
Onyango, A. N. (2026) · Comprehensive physiology · doi:10.1002/cph4.70285
Metadata
- Authors
- Kubota, N., Kubota, T., Kajiwara, E., Iwamura, T., Kumagai, H., Watanabe, T., Inoue, M., Takamoto, I., Sasako, T., Kumagai, K., Kohjima, M., Nakamuta, M., Moroi, M., Sugi, K., Noda, T., Terauchi, Y., Ueki, K., & Kadowaki, T.
- Affiliations
- National Institute of Biomedical Innovation, Health and Nutrition (JP)
- Toho University (JP)
- The University of Tokyo (JP)
- Hokkaido University (JP)
- Tokyo Medical University (JP)
- National Kyushu Medical Center (JP)
- Japanese Foundation For Cancer Research (JP)
- Yokohama City University (JP)
- Corresponding author
- Kubota, Naoto
- Kadowaki, Takashi
- ORCID
- Venue
- Nature Communications
- Published
- 2016-10-06
- Volume
- 7
- Issue
- 1
- Pages
- 12977-12977
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC5059684
- OpenAlex
- W2529090544
- Cited by
- 143
- References
- 46
- Citations by year
- 2026: 22 · 2025: 19 · 2024: 17 · 2023: 19 · 2022: 11 · 2021: 17 · 2020: 15 · 2019: 7 · 2018: 8 · 2017: 7 · 2016: 1
- FWCI
- 3.96
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Takeda Science Foundation
- Ministry of Education, Culture, Sports, Science and Technology (20229008, 18209033, 19591037, 16209030, 21390279)
- Ono Medical Research Foundation
- Japan Society for the Promotion of Science (16K15488, 16H05329, 26000012)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- IRS-1, insulin receptor substrate 2, liver zonation, periportal zone, perivenous zone, gluconeogenesis, lipogenesis, hyperinsulinemia, obesity, diabetes mellitus
- MeSH terms
- Animals, Cell Nucleus, Diabetes Mellitus, Diabetes Mellitus, Experimental, Gluconeogenesis, Homeostasis, Humans, Hyperinsulinism, Insulin, Insulin Resistance, Liver, Male, Mice, Inbred C57BL, Obesity, Receptor, Insulin, Signal Transduction, Antigens, CD, Mice, Knockout, Mice, Insulin Receptor Substrate Proteins, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.